Bullboard - Stock Discussion Forum Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK... see more

Add To Watchlist

TSX:FRX - Post Discussion

Fennec Pharmaceuticals Ord Shs > IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

View:

Post by AviseAnalytics on Dec 09, 2021 7:08am

IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

$FENC

Fennec Pharmaceuticals (NASDAQ:FENC), a "specialty pharmaceutical company", received a CRL from the FDA for its New Drug Application (NDA) for PEDMARK™ (sodium thiosulfate), citing deficiencies in manufacturing.

This marks the second CRL for the Company. which earlier served a CRL for deficiencies in manufacturing in August 2020. Can Fennec Pharmaceuticals successfully address the concerns and obtain an approval for Pedmark?

Read on to find out more!

https://www.aviseanalytics.com/is-third-time-the-charm-for-fennec-pharmaceuticals/

331

Comment

Comment by willyk3 on Dec 09, 2021 9:46am

Absolute dud The fact that they failed at the manufacturing revisions shows that they and their mfg partner are incompetant at this aspect of the process. Wonder who that is ? Drug works...allbeit a dangerous potion...fraught with potential lawsuits if improperly doled out Maybe they should give Jan a call at Acasti...she sure knows how to execute...LOL

253

Comment

Comment by willyk3 on Dec 13, 2021 8:05am

The obvious solution at this stage is to just sell the darn company (at a discount) to a real pharmaceautical company who has the capability to complete the process

248

Comment

Fennec Pharmaceuticals Ord Shs